[HTML][HTML] Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

RC Smallridge, LA Marlow… - Endocrine-related …, 2009 - erc.bioscientifica.com
Anaplastic thyroid cancer (ATC) is a rare malignancy. While external beam radiation therapy
has improved locoregional control, the median survival of∼ 4 months has not changed in …

Systems biology and genomics of breast cancer

CM Perou, AL Børresen-Dale - Cold Spring Harbor …, 2011 - cshperspectives.cshlp.org
It is now accepted that breast cancer is not a single disease, but instead it is composed of a
spectrum of tumor subtypes with distinct cellular origins, somatic changes, and etiologies …

In situ force mapping of mammary gland transformation

JI Lopez, I Kang, WK You, DM McDonald… - Integrative …, 2011 - academic.oup.com
Tumor progression is characterized by an incremental stiffening of the tissue. The
importance of tissue rigidity to cancer is appreciated, yet the contribution of specific tissue …

Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells

CC Ong, AM Jubb, PM Haverty… - Proceedings of the …, 2011 - National Acad Sciences
p21-activated kinases (PAKs) are serine/threonine protein kinases that serve as important
mediators of Rac and Cdc42 GTPase function as well as pathways required for Ras-driven …

[HTML][HTML] Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

IT Yeh, MA Martin, RS Robetorye, AR Bolla… - Modern pathology, 2009 - Elsevier
The HER2 gene is an important prognostic and therapeutic marker in newly diagnosed
breast cancer. Currently, HER2 status is most frequently determined by …

RNA and DNA microarrays

SC Sealfon, TT Chu - Biological Microarrays: Methods and Protocols, 2011 - Springer
The development of microarray technology has revolutionized RNA and deoxyribonucleic
acid (DNA) research. In contrast with traditional biological assays, microarrays allow the …

Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer

S Di Cosimo, M Silvestri, C De Marco, A Calzoni… - Scientific Reports, 2024 - nature.com
Chromosomal Instability (CIN) is a common and evolving feature in breast cancer. Large-
scale Transitions (LSTs), defined as chromosomal breakages leading to gains or losses of at …

Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations

K Unger, J Wienberg, A Riches… - Endocrine-related …, 2010 - erc.bioscientifica.com
Components of the tumour microenvironment initiate and promote cancer development. In
this study, we investigated the stromal component of parathyroid neoplasia …

Applications of computational homology to the analysis of treatment response in breast cancer patients

D DeWoskin, J Climent, I Cruz-White… - Topology and its …, 2010 - Elsevier
The experimental method comparative genomic hybridization (CGH) array provides a full
picture of chromosome amplifications and deletions of an individual's genome. The multi …

Genomic differences between estrogen receptor (ER)‐positive and ER‐negative human breast carcinoma identified by single nucleotide polymorphism array …

M Fang, J Toher, M Morgan, J Davison… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Estrogen receptor (ER) remains one of the most important biomarkers for
breast cancer subtyping and prognosis, and comparative genome hybridization has greatly …